Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.

Published in:

2021

By:

• Merat, Shahin;
• Sharifi, Amir-Houshang;
• Poustchi, Hossein;
• Hajiani, Eskandar;
• Gharavi, Abdolsamad;
• Karimi, Jalal;
• Mansour-Ghanaei, Fariborz;
• Fattahi, Mohammad-Reza;
• Ahmadi, Lida;
• Somi, Mohammad-Hossein;
• Kalantari, Hamid;
• Ghadir, Mohammad-Reza;
• Sheikhesmaeili, Farshad;
• Baniasadi, Nadieh;
• Sohrabi, Masoudreza;
• Moosavy, Seyedhamid;
• Ziaee, Masood;
• Zahedi, Mohammad-Javad;
• Mokhtare, Marjan;
• Sali, Shahnaz

Publication type:

Correction Notice